Johnson & Johnson is rumored to be considering the acquisition of a local baby-care product vendor Shanghai Elsker in China, a move that could strengthen its foothold in the rapidly-growing Chinese baby-care market.
Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.
Janssen Biotech will make an upfront payment of $55 million for the license and Johnson & Johnson Development Corp would invest 475 million Danish crowns ($80 million) in new Genmab shares, the company said.
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.
The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.
Berkshire pared its holdings of Johnson & Johnson (JNJ) by about two-thirds to 10.3 million shares. The world's biggest health- products maker was ordered in April to pay more than $1.1 billion in fines after an Arkansas jury found the firm misled ...
Johnson & Johnson lost a bid to have a Louisiana appeals court throw out an award of almost $258 million that a jury ordered it to pay state officials over the marketing of its Risperdal antipsychotic drug.